Text and Data Mining valid from 2020-02-01
Received: 22 September 2017
Accepted: 18 November 2019
First Online: 5 February 2020
: R.B. owns equity in Ampressa Therapeutics; M.M. is the scientific advisory board chair of—and consultant for— OrigiMed, and receives research funding from Bayer and Ono Pharma, and patent royalties from LabCorp.; J.W. is a consultant for Nference Inc.; C.-Z.Z. is a cofounder and equity holder of Pillar Biosciences, a for-profit company specializing in the development of targeted sequencing assays.